Raymond James & Associates Increases Position in Morgan Stanley (NYSE:MS)

Raymond James & Associates boosted its position in Morgan Stanley (NYSE:MSFree Report) by 19.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,077,282 shares of the financial services provider’s stock after acquiring an additional 343,234 shares during the period. Raymond James & Associates owned about 0.13% of Morgan Stanley worth $216,536,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Capital International Investors boosted its position in shares of Morgan Stanley by 16.3% in the first quarter. Capital International Investors now owns 28,481,070 shares of the financial services provider’s stock worth $2,681,778,000 after acquiring an additional 3,981,528 shares during the last quarter. Public Employees Retirement Association of Colorado boosted its holdings in shares of Morgan Stanley by 600.8% in the 1st quarter. Public Employees Retirement Association of Colorado now owns 1,301,835 shares of the financial services provider’s stock valued at $122,581,000 after purchasing an additional 1,116,058 shares during the last quarter. Swedbank AB purchased a new stake in shares of Morgan Stanley during the 1st quarter valued at $87,558,000. Bessemer Group Inc. increased its holdings in shares of Morgan Stanley by 433.4% during the 1st quarter. Bessemer Group Inc. now owns 779,451 shares of the financial services provider’s stock worth $73,392,000 after buying an additional 633,319 shares during the last quarter. Finally, Zurich Insurance Group Ltd FI purchased a new position in shares of Morgan Stanley in the 2nd quarter worth $43,850,000. Hedge funds and other institutional investors own 84.19% of the company’s stock.

Insider Activity at Morgan Stanley

In related news, Director Stephen J. Luczo sold 60,000 shares of the stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $119.17, for a total value of $7,150,200.00. Following the completion of the transaction, the director now owns 138,363 shares in the company, valued at $16,488,718.71. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Morgan Stanley news, insider Mandell Crawley sold 3,500 shares of the firm’s stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $105.25, for a total transaction of $368,375.00. Following the completion of the sale, the insider now directly owns 43,224 shares in the company, valued at approximately $4,549,326. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Stephen J. Luczo sold 60,000 shares of the firm’s stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $119.17, for a total value of $7,150,200.00. Following the sale, the director now owns 138,363 shares of the company’s stock, valued at $16,488,718.71. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.24% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have issued reports on MS. JMP Securities reissued a “market perform” rating on shares of Morgan Stanley in a research report on Thursday, July 18th. Barclays boosted their price target on Morgan Stanley from $121.00 to $135.00 and gave the company an “overweight” rating in a research report on Thursday. Citigroup upped their target price on Morgan Stanley from $98.00 to $105.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 17th. Hsbc Global Res raised Morgan Stanley from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 4th. Finally, Oppenheimer downgraded Morgan Stanley from an “outperform” rating to a “market perform” rating in a research report on Wednesday, July 17th. One analyst has rated the stock with a sell rating, twelve have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Morgan Stanley presently has an average rating of “Hold” and a consensus target price of $107.56.

View Our Latest Analysis on MS

Morgan Stanley Stock Performance

MS opened at $121.06 on Friday. The business has a fifty day simple moving average of $103.38 and a 200-day simple moving average of $99.34. The firm has a market cap of $196.74 billion, a PE ratio of 22.05, a P/E/G ratio of 1.17 and a beta of 1.36. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 2.96. Morgan Stanley has a fifty-two week low of $69.42 and a fifty-two week high of $121.45.

Morgan Stanley Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Thursday, October 31st will be given a $0.925 dividend. The ex-dividend date of this dividend is Thursday, October 31st. This represents a $3.70 dividend on an annualized basis and a dividend yield of 3.06%. Morgan Stanley’s dividend payout ratio (DPR) is 67.40%.

About Morgan Stanley

(Free Report)

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Featured Articles

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.